Elkington + Fife LLP
Glyn is a European and UK Patent attorney whose practice spans a wide range of biotechnology subject-matter, from combination immunotherapies to PCR-based diagnostic assays. The majority of his work involves the drafting and prosecution of patent applications, and the handling of post-grant opposition proceedings, before the European Patent Office. In recent years, he has handled numerous high-value EPO oppositions and appeals involving biologics, immuno-oncology and cellular therapies, in addition to coordinating corresponding litigations in the High Court of England & Wales and elsewhere in Europe. Accordingly, he has an acute sense of the necessity of expert representation before the EPO, aligned with a holistic approach to the interplay between patents, SPCs and regulatory data protection.